Description

Methylprednisolone Tablets (4 mg / 8 mg / 16 mg)

Healthy Inc is a premier global provider of high-potency corticosteroid therapies. We provide premium Methylprednisolone Tablets, manufactured in WHO–GMP certified specialized hormonal production blocks. As a critical agent for suppressing inflammation and immune response, this product is a vital export for rheumatology clinics, oncology centers, and Ministry of Health (MOH) tenders in Southeast Asia, Africa, and the CIS region.

Product Overview

Methylprednisolone is a synthetic glucocorticoid derived from prednisolone. It is specifically engineered to provide enhanced anti-inflammatory activity with significantly reduced mineralocorticoid (sodium-retaining) properties, making it an ideal choice for patients requiring high-dose steroid therapy without excessive fluid retention.

The “Immune-Modulating” Specialist:

• Mechanism of Action: Methylprednisolone diffuses across cell membranes and binds to specific cytoplasmic glucocorticoid receptors. This complex enters the nucleus, binding to DNA to alter gene expression—specifically inhibiting the synthesis of pro-inflammatory cytokines and reducing the migration of polymorphonuclear leukocytes.
• High Potency Ratio: With an anti-inflammatory potency approximately 1.25 times greater than prednisolone and 5 times greater than hydrocortisone, it allows for effective symptom control at lower milligram dosages.
• Vascular Stability: By stabilizing lysosomal membranes and reducing capillary permeability, it rapidly addresses systemic inflammation in acute allergic or autoimmune flare-ups.

Technical & Manufacturing Specifications

Formulated for absolute dose uniformity and specialized hormonal containment.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from ISO 9001:2015 certified units.

• Hormonal Containment: Methylprednisolone is a highly active substance. Our manufacturing utilizes dedicated air handling units (AHU) and closed-loop granulation to ensure zero cross-contamination and operator safety.
• Micronized API: We utilize micronized Methylprednisolone to ensure uniform distribution in low-dose tablets (like 4 mg), ensuring every tablet provides the exact therapeutic response required for delicate titration.
• Stability Validation: Validated for Zone IVb climates. Our packaging ensures the tablets remain chemically stable and physically intact during transit to high-temperature regions in Africa and Southeast Asia.

Therapeutic Indications & Clinical Symptoms

• Endocrine Disorders: Primary or secondary adrenocortical insufficiency.
• Rheumatic Disorders: Adjunctive therapy for rheumatoid arthritis, ankylosing spondylitis, and acute bursitis.
• Collagen Diseases: Management of Systemic Lupus Erythematosus (SLE) and acute rheumatic carditis.
• Dermatologic Diseases: Treatment of Pemphigus, severe erythema multiforme (Stevens-Johnson syndrome).
• Allergic States: Control of severe or incapacitating allergic conditions (Asthma, Contact Dermatitis).

Dosage & Administration

• Titration: Dosage varies widely (4 mg to 48 mg/day) depending on the specific disease entity being treated.
• Withdrawal: Do not discontinue abruptly after long-term use. Gradual tapering is mandatory to prevent adrenal crisis.
• Safety Note: Long-term use requires monitoring for osteoporosis, hyperglycemia, and increased susceptibility to infection. Take with food to minimize gastric irritation.

Global Export & Contract Manufacturing Services

Healthy Inc is a verified Corticosteroid Exporter in Mumbai, catering to Specialty Rheumatology and Oncology Units. We offer Third Party Manufacturing for Methylprednisolone with full CTD Dossier and COPP support. Our logistics network ensures secure transit to Vietnam, Nigeria, Uzbekistan, and the Philippines, providing WHO-GMP quality at competitive B2B prices.

Commercial Inquiries

WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in